Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up von Fradet, Y., Bellmunt, J., Vaughn, D.J., Lee, J.L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Nam, K., Frenkl, T.L., Perini, R.F., de Wit, R., Bajorin, D.F.

Volltext

Detection of circulating tumor cells in patients with urothelial cancer von Gallagher, D. J., Milowsky, M. I., Ishill, N., Trout, A., Boyle, M. G., Riches, J., Fleisher, M., Bajorin, D. F.

Volltext

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy von BAJORIN, D. F, DODD, P. M, MAZUMDAR, M, FAZZARI, M, MCCAFFREY, J. A, SCHER, H. I, HERR, H, HIGGINS, G, BOYLE, M. G

Volltext

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma von MCCAFFREY, J. A, HILTON, S, MAZUMDAR, M, SADAN, S, KELLY, W. K, SCHER, H. I, BAJORIN, D. F

Volltext

Predicting Outcome to Chemotherapy in Patients With Germ Cell Tumors: The Value of the Rate of Decline of Human Chorionic Gonadotrophin and Alpha-Fetoprotein During Therapy von MAZUMDAR, M, BAJORIN, D. F, BACIK, J, HIGGINS, G, MOTZER, R. J, BOSL, G. J

Volltext

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host von Gallagher, D.J., Vijai, J., Hamilton, R.J., Ostrovnaya, I., Iyer, G., Garcia-Grossman, I.R., Kim, P.H., Przybylo, J.A., Alanee, S., Riches, J.C., Regazzi, A.M., Milowsky, M.I., Offit, K., Bajorin, D.F.

Volltext

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207 von Rosenberg, J. E., Halabi, S., Sanford, B. L., Himelstein, A. L., Atkins, J. N., Hohl, R. J., Millard, F., Bajorin, D. F., Small, E. J.

Volltext

Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors von Galsky, M.D., Camacho, L.H., Chiorean, E.G., Mulkerin, D., Hong, D.S., Oh, W.K., Bajorin, D.F.

Volltext

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgi... von Maluf, FC, Cordon-Cardo, C, Verbel, DA, Satagopan, JM, Boyle, MG, Herr, H, Bajorin, DF

Volltext

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome von HERR, H. W, BAJORIN, D. F, SCHER, H. I

Volltext

Commentary on “DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma.” von Teo, MY, Bambury, RM, Zabor, EC, Jordan, E, Al-Ahmadie, H, Boyd, ME, Bouvier, N, Mullane, SA, Cha, EK, Roper, N, Ostrovnaya, I, Hyman, DM, Bochner, BH, Arcila, ME, Solit, DB, Berger, MF, Bajorin, DF, Bellmunt, J, Iyer, G, Rosenberg, JE

Volltext

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors von MOTZER, R. J, MAZUMDAR, M, BAJORIN, D. F, BOSL, G. J, LYN, P, VLAMIS, V

Volltext

BAYOU: Phase II study of efficacy and safety of durvalumab plus olaparib as first-line therapy in cisplatin-ineligible patients (pts) with stage iv urothelial cancer (UC) von Rosenberg, J.E., Bajorin, D.F., Smith, A., D’Cruz, C., Lanasa, M.

Volltext

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity von MOTZER, R. J, MADHU MAZUMDAR, BOSL, G. J, BAJORIN, D. F, AMSTERDAM, A, VLAMIS, V

Volltext

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival von MCCAFFREY, J. A, MAZUMDAR, M, BAJORIN, D. F, BOSL, G. J, VLAMIS, V, MOTZER, R. J

Volltext

Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients von MOTZER, R. J, MAZUMDAR, M, BOSL, G. J, SHEINFELD, J, BAJORIN, D. F, MACAPINLAC, H. A, BAINS, M, REICH, L, FLOMBAUM, C, MARIANI, T, TONG, W. P

Volltext

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC von SARKIS, A. S, BAJORIN, D. F, REUTER, V. E, HERR, H. W, NETTO, G, ZUO-FENG ZHANG, SCHULTZ, P. K, CORDON-CARDO, C, SCHER, H. I

Volltext

Outcome of Postchemotherapy Surgery After Treatment With Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients With Unresectable or Metastatic Transitional Cell Carcino... von DODD, P. M, MCCAFFREY, J. A, HERR, H, MAZUMDAR, M, BACIK, J, HIGGINS, G, BOYLE, M. G, SCHER, H. I, BAJORIN, D. F

Volltext

Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center von PUC, H. S, HEELAN, R, MADHU MAZUMDAR, HERR, H, SCHEINFELD, J, VLAMIS, V, BAJORIN, D. F, BOSL, G. J, MENCEL, P, MOTZER, R. J

Volltext

Recommendations for a Global Core Curriculum in Medical Oncology von Hansen, H. H., Bajorin, D. F., Muss, H. B., Purkalne, G., Schrijvers, D., Stahel, R.

Volltext